ANGPT2 and ischemia: The pathophysiological basis likely involves ischemia-driven upregulation of non-vascular endothelial growth factor angiogenic factors (platelet-derived growth factor [PlGF], angiopoietin-2 [Ang-2]) that bypass VEGF blockade (30).